Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route

Author： Nasr Maha   Taha Ismail   Hathout Rania M.  

Publisher： Informa Healthcare

ISSN： 1521-0464

Source： Drug Delivery, Vol.20, Iss.8, 2013-11, pp. : 311-318

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interview with Vladimir P Torchilin: liposomal carriers for drug delivery

By Torchilin Vladimir P  

Therapeutic Delivery, Vol. 4, Iss. 5, 2013-05 ,pp. : 537-538

Future Science

Access to resources Recommend Favorite

Effect of Delivery Route on Pulmonary Response to Oncostatin M

By Li Hong Lan   Mathias Neil   Timoszyk Julita   Stouffer Bruce   Wall Doris  

Journal of Drug Targeting, Vol. 10, Iss. 1, 2002-01 ,pp. : 55-62

Informa Healthcare

Access to resources Recommend Favorite

Translational siRNA Therapeutics Using Liposomal Carriers: Prospects & Challenges

By  

Current Gene Therapy, Vol. 12, Iss. 4, 2012-08 ,pp. : 315-332

Bentham Science Publishers

Access to resources Recommend Favorite

Inhalable Microparticles as Carriers for Pulmonary Delivery of Thymopentin-Loaded Solid Lipid Nanoparticles

By Li Yan-Zhen   Sun Xun   Gong Tao   Liu Jie   Zuo Jiao   Zhang Zhi-Rong  

Pharmaceutical Research, Vol. 27, Iss. 9, 2010-09 ,pp. : 1977-1986

Springer Publishing Company

Access to resources Recommend Favorite

Drug, enzyme and peptide delivery using erythrocytes as carriers

By Millan C.G.   Marinero M.L.S.   Castaneda A.Z.   Lanao J.M.  

Journal of Controlled Release, Vol. 95, Iss. 1, 2004-02 ,pp. : 27-49

Elsevier

Access to resources Recommend Favorite